For 15 years and counting, the Johnson & Johnson talc litigation saga continues to play out in our nation’s court system, adding another exhibit to the unfortunate truism that the ...
For 15 years and counting, the Johnson & Johnson talc litigation saga continues to play out in our nation’s court system, ...
The fate of Johnson & Johnson’s latest push to use bankruptcy courts to end thousands of cancer lawsuits tied to its iconic baby powder now hinges on a high-stakes trial in January. After months ...
Historically, market corrections of 10% or more are common but long-term investors have still enjoyed solid returns. The report states that elections and Fed rate cuts may also impact the market ...
QuantumScape released its Q3 2024 business report this afternoon, and the biggest news is an update regarding the progress of its solid-state battery development and production. According to the ...
With Johnson & Johnson sweetening the pot and mustering up the support of 83% of those who claim that the company’s talc products caused their cancer, it had appeared that the sides were ...
J&J’s OPSUMIT and UPTRAVI posted solid growth of 17.4% and 15.2% ... they revised their EPS due to the V-Wave acquisition, and talc litigation costs. In terms of their finances, J&J closed ...
However, it does remove some of the safe and stodgy parts of the business that made J&J a rock-solid dividend stock ... with lawsuits that allege its talc-based products led to cancer development.
Today’s LoLdle was another easy one after yesterday’s walk in the park. I got it on my first try, but if you didn’t, read on for the answer to the Oct. 18 quote. Only two champions are ...
Johnson & Johnson reported solid Q3 revenues of $22.5bn ... With a potential resolution to talc litigation and a robust pipeline, JNJ stock is upgraded to “Buy,” offering a 3% dividend ...
People who voted to settle their baby power-related health claims against Johnson & Johnson should have their ballots thrown out because the consumer products giant rigged the tally, according to ...